Theorem Clinical Research

RPS

Report: CRO market to top $30 billion by 2018

Monday, November 11, 2013 03:06 PM

A new report by healthcare sector corporate finance and strategy specialist Results Healthcare says the CRO sector is seeing a recovery, driven by improved optimism across the biopharma industry, the sector’s largest customer group, where many key CRO customers are now at the tail end of multi-year patent cliffs and are stepping up investments into their pipelines, particularly products in late-stage development.

More... »

Quest Diagnostics

PRA, RPS merger completed

Wednesday, September 25, 2013 12:23 PM

CRO PRA International has completed its merger with ReSearch Pharmaceutical Services (RPS) and the closing of the acquisition by Kohlberg Kravis Roberts.  

More... »


RPS, PRA to merge under KKR ownership

Wednesday, July 31, 2013 01:51 PM

Global investment firm KKR has signed a definitive agreement to acquire ReSearch Pharmaceutical Services (RPS), a global CRO, from Warburg Pincus.

More... »

ReSearch Pharmaceutical, Asklep create joint venture in Japan

Friday, March 29, 2013 03:03 PM

ReSearch Pharmaceutical Services (RPS), a global CRO, and Asklep, a Japanese CRO, have created a joint venture company (JVC) to deliver leading-edge R&D outsourcing solutions in Japan to the biopharmaceutical and medical device industries. 

More... »

RPS appoints Stephen Kasay as CIO

Thursday, August 30, 2012 03:02 PM

ReSearch Pharmaceutical Services (RPS), a Fort Washington, Penn.-based next generation global CRO that provides comprehensive phase I-IV clinical development solutions, has appointed Stephen Kasay as chief information officer.

More... »

Survey: Top CROs doubled workforce over past decade

Monday, October 24, 2011 08:02 AM

Over the last 10 years, the top nine global CROs have more than doubled their workforce, which now exceeds 72,000 employees, and their revenues have increased at a compound annualized rate of 11% as they increasingly play a larger and more integral role in the drug development infrastructure, according to a new Association of Clinical Research Organizations (ACRO) member survey.

More... »

Carlyle Partners, Hellman & Friedman to acquire PPD for $3.9 billion, take the CRO private

Monday, October 10, 2011 08:02 AM

It’s official: Large equity investors Carlyle Partners and Hellman & Friedman Capital Partners are buying publicly traded PPD, taking the CRO private.

More... »

PRA on the block, too?

Monday, August 8, 2011 08:02 AM

There was much hoopla made about PPD possibly being for sale after the Wall Street Journal published a story saying as much in mid-July. But what about its smaller competitor, PRA International?

More... »

RPS to Raise $100 Million in IPO

Wednesday, June 23, 2010 08:15 AM

ReSearch Pharmaceutical Services (RPS) plans an initial public offering in the U.S. on the Nasdaq exchange. The Fort Washington, Pa.-based contract research organization (CRO ) seeks to raise $100 million from the IPO.

More... »

RPS on Global Acquisition Spree

Monday, April 13, 2009 08:00 AM

ReSearch Pharmaceutical Services’ (RPS) plan to acquire a small contract research organization (CRO) in China will expand the company’s capabilities in Asia, but the deal is also part of a larger plan to expand RPS throughout the world by multiple acquisitions.

More... »


CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs